Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colectomy | 27 | 2024 | 696 | 5.370 |
Why?
|
Rectal Neoplasms | 24 | 2025 | 1183 | 4.560 |
Why?
|
Rectum | 18 | 2024 | 897 | 3.710 |
Why?
|
Anastomotic Leak | 9 | 2024 | 170 | 3.440 |
Why?
|
Digestive System Surgical Procedures | 13 | 2021 | 584 | 3.140 |
Why?
|
Laparoscopy | 16 | 2024 | 2038 | 2.850 |
Why?
|
Appendicitis | 6 | 2023 | 680 | 2.750 |
Why?
|
Anus Neoplasms | 7 | 2020 | 336 | 2.720 |
Why?
|
Colostomy | 9 | 2024 | 107 | 2.670 |
Why?
|
Diverticulitis, Colonic | 8 | 2024 | 140 | 2.400 |
Why?
|
Abdominal Abscess | 4 | 2022 | 152 | 2.380 |
Why?
|
Colonic Neoplasms | 13 | 2024 | 2535 | 2.010 |
Why?
|
Colon | 15 | 2024 | 1797 | 1.960 |
Why?
|
Colorectal Surgery | 7 | 2019 | 125 | 1.950 |
Why?
|
Ileostomy | 4 | 2024 | 122 | 1.870 |
Why?
|
Postoperative Complications | 33 | 2024 | 15831 | 1.730 |
Why?
|
Colonic Diseases | 6 | 2015 | 204 | 1.660 |
Why?
|
Intestinal Perforation | 5 | 2021 | 254 | 1.550 |
Why?
|
Anastomosis, Surgical | 13 | 2024 | 992 | 1.480 |
Why?
|
Colorectal Neoplasms | 15 | 2024 | 6965 | 1.420 |
Why?
|
Appendectomy | 7 | 2023 | 445 | 1.390 |
Why?
|
Quality Improvement | 9 | 2024 | 3850 | 1.310 |
Why?
|
Carcinoma in Situ | 3 | 2019 | 784 | 1.290 |
Why?
|
Diverticulitis | 4 | 2022 | 187 | 1.210 |
Why?
|
Neoadjuvant Therapy | 8 | 2025 | 2902 | 1.170 |
Why?
|
Proctocolectomy, Restorative | 4 | 2019 | 191 | 1.080 |
Why?
|
Microsatellite Instability | 2 | 2021 | 726 | 1.080 |
Why?
|
Neoplasms, Second Primary | 4 | 2023 | 1062 | 1.070 |
Why?
|
Adenocarcinoma | 10 | 2025 | 6359 | 1.070 |
Why?
|
Databases, Factual | 13 | 2024 | 8065 | 1.000 |
Why?
|
Retrospective Studies | 75 | 2025 | 81657 | 0.990 |
Why?
|
Intestinal Obstruction | 4 | 2020 | 433 | 0.960 |
Why?
|
Rectal Diseases | 4 | 2019 | 141 | 0.910 |
Why?
|
Rectal Prolapse | 2 | 2014 | 33 | 0.850 |
Why?
|
Surgical Wound Infection | 7 | 2018 | 1547 | 0.830 |
Why?
|
Hospital Mortality | 10 | 2024 | 5344 | 0.810 |
Why?
|
Length of Stay | 14 | 2024 | 6491 | 0.780 |
Why?
|
Reoperation | 10 | 2024 | 4325 | 0.780 |
Why?
|
Intestines | 4 | 2022 | 1904 | 0.740 |
Why?
|
Crohn Disease | 3 | 2024 | 2286 | 0.740 |
Why?
|
Patient Readmission | 8 | 2024 | 3283 | 0.720 |
Why?
|
Neoplasm Staging | 22 | 2024 | 11218 | 0.720 |
Why?
|
Genital Neoplasms, Female | 2 | 2019 | 534 | 0.710 |
Why?
|
Cross Infection | 4 | 2011 | 1427 | 0.700 |
Why?
|
Anal Canal | 4 | 2019 | 375 | 0.700 |
Why?
|
Middle Aged | 80 | 2025 | 223267 | 0.690 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 50 | 0.650 |
Why?
|
Genital Neoplasms, Male | 1 | 2019 | 68 | 0.650 |
Why?
|
Aged | 70 | 2025 | 171344 | 0.630 |
Why?
|
Colon, Transverse | 2 | 2021 | 25 | 0.610 |
Why?
|
Colon, Sigmoid | 2 | 2020 | 124 | 0.600 |
Why?
|
Humans | 137 | 2025 | 766812 | 0.590 |
Why?
|
Female | 94 | 2025 | 396532 | 0.580 |
Why?
|
Male | 88 | 2025 | 364154 | 0.580 |
Why?
|
United States | 42 | 2024 | 72945 | 0.570 |
Why?
|
Urinary Tract Infections | 5 | 2017 | 804 | 0.540 |
Why?
|
Quality Indicators, Health Care | 2 | 2017 | 1804 | 0.530 |
Why?
|
Medicare | 3 | 2022 | 6813 | 0.510 |
Why?
|
Gastric Bypass | 4 | 2023 | 820 | 0.500 |
Why?
|
Treatment Outcome | 30 | 2024 | 65286 | 0.500 |
Why?
|
Patient Admission | 3 | 2011 | 1364 | 0.500 |
Why?
|
Suture Techniques | 2 | 2018 | 775 | 0.500 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2007 | 264 | 0.490 |
Why?
|
Adult | 54 | 2025 | 223305 | 0.490 |
Why?
|
Preoperative Care | 1 | 2024 | 2253 | 0.470 |
Why?
|
After-Hours Care | 1 | 2015 | 102 | 0.460 |
Why?
|
Ascites | 1 | 2016 | 336 | 0.460 |
Why?
|
SEER Program | 7 | 2018 | 1444 | 0.460 |
Why?
|
Surgical Stomas | 2 | 2014 | 45 | 0.450 |
Why?
|
Intestinal Volvulus | 1 | 2015 | 82 | 0.450 |
Why?
|
Hospitals | 7 | 2021 | 3885 | 0.450 |
Why?
|
Aged, 80 and over | 30 | 2024 | 59548 | 0.450 |
Why?
|
Esophageal Perforation | 1 | 2014 | 65 | 0.440 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.430 |
Why?
|
Clostridium Infections | 2 | 2011 | 563 | 0.430 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4050 | 0.420 |
Why?
|
Feedback | 1 | 2017 | 797 | 0.420 |
Why?
|
Program Evaluation | 2 | 2022 | 2504 | 0.420 |
Why?
|
Fistula | 1 | 2014 | 213 | 0.400 |
Why?
|
Stomach Diseases | 1 | 2014 | 134 | 0.400 |
Why?
|
Health Expenditures | 2 | 2022 | 2389 | 0.400 |
Why?
|
Endometriosis | 2 | 2024 | 868 | 0.380 |
Why?
|
Risk Adjustment | 2 | 2015 | 597 | 0.380 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1762 | 0.380 |
Why?
|
Multivariate Analysis | 11 | 2020 | 12064 | 0.380 |
Why?
|
Fecal Incontinence | 3 | 2020 | 246 | 0.380 |
Why?
|
Colitis, Ulcerative | 4 | 2023 | 1920 | 0.360 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2011 | 95 | 0.350 |
Why?
|
Risk Factors | 26 | 2024 | 74889 | 0.350 |
Why?
|
Ostomy | 1 | 2010 | 34 | 0.340 |
Why?
|
Lymph Node Excision | 3 | 2024 | 1267 | 0.340 |
Why?
|
Survival Rate | 9 | 2024 | 12826 | 0.340 |
Why?
|
Tissue Adhesions | 1 | 2011 | 222 | 0.340 |
Why?
|
Cohort Studies | 17 | 2023 | 41706 | 0.330 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2009 | 146 | 0.320 |
Why?
|
Patient Discharge | 5 | 2021 | 3466 | 0.320 |
Why?
|
Hospices | 2 | 2023 | 245 | 0.320 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2009 | 388 | 0.320 |
Why?
|
Health Status Disparities | 1 | 2021 | 1880 | 0.320 |
Why?
|
Sepsis | 2 | 2020 | 2604 | 0.310 |
Why?
|
Health Care Costs | 2 | 2021 | 3240 | 0.300 |
Why?
|
Developing Countries | 1 | 2021 | 2912 | 0.300 |
Why?
|
Pressure Ulcer | 1 | 2009 | 158 | 0.300 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1776 | 0.300 |
Why?
|
Colonic Pouches | 2 | 2020 | 122 | 0.290 |
Why?
|
Hospitalization | 7 | 2020 | 10816 | 0.290 |
Why?
|
Abscess | 2 | 2022 | 606 | 0.290 |
Why?
|
California | 4 | 2015 | 1435 | 0.290 |
Why?
|
Colonoscopy | 4 | 2020 | 1409 | 0.290 |
Why?
|
Colitis | 2 | 2023 | 1238 | 0.290 |
Why?
|
Prospective Studies | 16 | 2024 | 54872 | 0.280 |
Why?
|
Long-Term Care | 1 | 2011 | 630 | 0.280 |
Why?
|
Fundoplication | 1 | 2008 | 146 | 0.280 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1768 | 0.280 |
Why?
|
Logistic Models | 9 | 2020 | 13276 | 0.280 |
Why?
|
Guideline Adherence | 1 | 2017 | 2233 | 0.270 |
Why?
|
Acute Disease | 4 | 2023 | 7240 | 0.270 |
Why?
|
Diverticulum | 2 | 2020 | 137 | 0.270 |
Why?
|
Lumbosacral Plexus | 1 | 2006 | 53 | 0.260 |
Why?
|
Specialization | 1 | 2011 | 779 | 0.260 |
Why?
|
Total Quality Management | 1 | 2007 | 264 | 0.250 |
Why?
|
Surgical Procedures, Operative | 2 | 2014 | 1931 | 0.250 |
Why?
|
Reperfusion Injury | 3 | 2003 | 1043 | 0.250 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1960 | 0.250 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1203 | 0.250 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3837 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.240 |
Why?
|
Seasons | 1 | 2011 | 1519 | 0.240 |
Why?
|
Mass Screening | 2 | 2021 | 5454 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2841 | 0.240 |
Why?
|
Abdomen | 3 | 2017 | 1137 | 0.230 |
Why?
|
Constipation | 2 | 2019 | 568 | 0.220 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4356 | 0.220 |
Why?
|
Ileum | 2 | 2018 | 558 | 0.220 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3431 | 0.220 |
Why?
|
Liver | 4 | 2003 | 7571 | 0.210 |
Why?
|
Prognosis | 12 | 2025 | 29959 | 0.210 |
Why?
|
Sex Distribution | 2 | 2020 | 2274 | 0.210 |
Why?
|
Recurrence | 5 | 2019 | 8507 | 0.210 |
Why?
|
Lymph Nodes | 4 | 2019 | 3468 | 0.210 |
Why?
|
Evoked Potentials, Motor | 1 | 2006 | 463 | 0.210 |
Why?
|
Cathartics | 1 | 2024 | 129 | 0.210 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2188 | 0.210 |
Why?
|
Urinary Catheterization | 2 | 2017 | 195 | 0.210 |
Why?
|
Incidence | 9 | 2023 | 21527 | 0.200 |
Why?
|
Time Factors | 10 | 2020 | 40149 | 0.200 |
Why?
|
Lymphopenia | 1 | 2025 | 300 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 90 | 0.200 |
Why?
|
Postoperative Period | 4 | 2024 | 1824 | 0.200 |
Why?
|
Patient Preference | 1 | 2009 | 946 | 0.200 |
Why?
|
Ischemic Preconditioning | 1 | 2002 | 89 | 0.200 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 210 | 0.190 |
Why?
|
Lymphatic Metastasis | 6 | 2020 | 2901 | 0.190 |
Why?
|
Benchmarking | 2 | 2010 | 1056 | 0.190 |
Why?
|
Age Factors | 7 | 2024 | 18397 | 0.190 |
Why?
|
Defecation | 2 | 2020 | 190 | 0.180 |
Why?
|
Risk Assessment | 4 | 2019 | 24299 | 0.180 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1721 | 0.180 |
Why?
|
Critical Care | 1 | 2014 | 2714 | 0.180 |
Why?
|
Neoplasm Invasiveness | 4 | 2022 | 3610 | 0.180 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 80 | 0.180 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15425 | 0.180 |
Why?
|
Therapeutic Irrigation | 2 | 2018 | 297 | 0.170 |
Why?
|
Phosphatidylcholines | 1 | 2002 | 404 | 0.170 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7475 | 0.170 |
Why?
|
Liver Transplantation | 3 | 2003 | 2416 | 0.170 |
Why?
|
Cryopreservation | 2 | 2003 | 727 | 0.170 |
Why?
|
Disease-Free Survival | 5 | 2022 | 6853 | 0.170 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 44 | 0.170 |
Why?
|
Reaction Time | 1 | 2006 | 2085 | 0.170 |
Why?
|
Intestinal Fistula | 1 | 2020 | 146 | 0.170 |
Why?
|
Sigmoidoscopy | 1 | 2020 | 150 | 0.160 |
Why?
|
Pelvis | 2 | 2020 | 737 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 5 | 2025 | 6514 | 0.160 |
Why?
|
Obesity, Morbid | 2 | 2023 | 1292 | 0.160 |
Why?
|
Coronary Artery Bypass | 1 | 2008 | 2189 | 0.160 |
Why?
|
Comorbidity | 5 | 2022 | 10580 | 0.160 |
Why?
|
Renal Insufficiency | 2 | 2015 | 811 | 0.150 |
Why?
|
Sex Factors | 3 | 2020 | 10619 | 0.150 |
Why?
|
Cold Temperature | 1 | 2002 | 793 | 0.150 |
Why?
|
Intussusception | 1 | 2019 | 114 | 0.150 |
Why?
|
Protein Kinase C | 1 | 2002 | 1206 | 0.150 |
Why?
|
Young Adult | 11 | 2024 | 59939 | 0.150 |
Why?
|
Developed Countries | 1 | 2021 | 453 | 0.140 |
Why?
|
Auscultation | 1 | 2017 | 38 | 0.140 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12536 | 0.140 |
Why?
|
Air | 1 | 2018 | 183 | 0.140 |
Why?
|
Income | 2 | 2021 | 1876 | 0.140 |
Why?
|
Marital Status | 1 | 2018 | 426 | 0.140 |
Why?
|
New York | 3 | 2020 | 879 | 0.140 |
Why?
|
Internship and Residency | 2 | 2015 | 5943 | 0.140 |
Why?
|
Diverticulosis, Colonic | 1 | 2016 | 9 | 0.140 |
Why?
|
Epidermis | 1 | 2019 | 539 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.130 |
Why?
|
Nursing Homes | 2 | 2023 | 1084 | 0.130 |
Why?
|
Propensity Score | 1 | 2024 | 1972 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2023 | 2429 | 0.130 |
Why?
|
Cause of Death | 3 | 2024 | 3717 | 0.130 |
Why?
|
Venous Thrombosis | 2 | 2017 | 1321 | 0.130 |
Why?
|
Morbidity | 2 | 2022 | 1754 | 0.130 |
Why?
|
Medicaid | 1 | 2009 | 2836 | 0.130 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1012 | 0.130 |
Why?
|
Feasibility Studies | 2 | 2024 | 5306 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 907 | 0.130 |
Why?
|
Ablation Techniques | 1 | 2018 | 254 | 0.130 |
Why?
|
General Surgery | 2 | 2019 | 1720 | 0.130 |
Why?
|
Malnutrition | 1 | 2022 | 629 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9407 | 0.120 |
Why?
|
Cost Savings | 1 | 2021 | 903 | 0.120 |
Why?
|
Adolescent | 9 | 2020 | 88902 | 0.120 |
Why?
|
Postoperative Care | 1 | 2022 | 1480 | 0.120 |
Why?
|
Colonic Polyps | 1 | 2020 | 557 | 0.120 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13489 | 0.120 |
Why?
|
Vegetables | 1 | 2020 | 1199 | 0.120 |
Why?
|
World Health Organization | 1 | 2021 | 1327 | 0.120 |
Why?
|
Mortality | 2 | 2017 | 2908 | 0.120 |
Why?
|
Robotics | 1 | 2021 | 807 | 0.110 |
Why?
|
Child | 7 | 2022 | 80670 | 0.110 |
Why?
|
Drug Utilization | 1 | 2020 | 1188 | 0.110 |
Why?
|
NF-kappa B | 1 | 2002 | 2493 | 0.110 |
Why?
|
Quality of Life | 5 | 2024 | 13476 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1274 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1514 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 915 | 0.110 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39312 | 0.110 |
Why?
|
Perineum | 1 | 2014 | 212 | 0.110 |
Why?
|
Irritable Bowel Syndrome | 1 | 2019 | 454 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2426 | 0.110 |
Why?
|
Inpatients | 2 | 2023 | 2566 | 0.100 |
Why?
|
Survival Analysis | 3 | 2019 | 10101 | 0.100 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3411 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1156 | 0.100 |
Why?
|
Perioperative Care | 1 | 2020 | 1043 | 0.100 |
Why?
|
Liver Circulation | 2 | 2002 | 163 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 641 | 0.100 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 369 | 0.090 |
Why?
|
Physicians | 1 | 2009 | 4591 | 0.090 |
Why?
|
Emergencies | 2 | 2019 | 1223 | 0.090 |
Why?
|
Terminal Care | 1 | 2023 | 1769 | 0.090 |
Why?
|
Bile | 2 | 2003 | 300 | 0.090 |
Why?
|
Prevalence | 5 | 2020 | 15835 | 0.090 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2783 | 0.090 |
Why?
|
Cost of Illness | 1 | 2021 | 1949 | 0.090 |
Why?
|
Hemorrhoids | 1 | 2010 | 19 | 0.090 |
Why?
|
Age Distribution | 1 | 2016 | 2869 | 0.090 |
Why?
|
Neoplasms | 2 | 2022 | 22350 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15912 | 0.090 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8540 | 0.090 |
Why?
|
Mediastinitis | 1 | 2009 | 49 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 602 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5367 | 0.080 |
Why?
|
Overweight | 1 | 2021 | 2447 | 0.080 |
Why?
|
Embolism, Air | 1 | 2009 | 111 | 0.080 |
Why?
|
Swine | 4 | 2003 | 5985 | 0.080 |
Why?
|
Delphi Technique | 2 | 2012 | 892 | 0.080 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 624 | 0.080 |
Why?
|
Perioperative Period | 2 | 2020 | 252 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2510 | 0.080 |
Why?
|
Massachusetts | 2 | 2019 | 8890 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2603 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3552 | 0.070 |
Why?
|
Cholecystitis, Acute | 1 | 2008 | 81 | 0.070 |
Why?
|
Health Promotion | 1 | 2020 | 2209 | 0.070 |
Why?
|
Arizona | 1 | 2007 | 108 | 0.070 |
Why?
|
Registries | 2 | 2024 | 8352 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2697 | 0.070 |
Why?
|
Genotype | 1 | 2022 | 13036 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3853 | 0.070 |
Why?
|
Minnesota | 1 | 2007 | 339 | 0.070 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 1126 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3111 | 0.070 |
Why?
|
Radiotherapy | 2 | 2011 | 1497 | 0.070 |
Why?
|
Public Health | 1 | 2020 | 2680 | 0.070 |
Why?
|
Shock, Septic | 1 | 2013 | 772 | 0.070 |
Why?
|
Regression Analysis | 2 | 2014 | 6329 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2020 | 6548 | 0.070 |
Why?
|
Catheter-Related Infections | 1 | 2009 | 279 | 0.070 |
Why?
|
Cholecystectomy | 1 | 2008 | 409 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2010 | 1104 | 0.070 |
Why?
|
Disease Progression | 2 | 2024 | 13642 | 0.060 |
Why?
|
Laparotomy | 1 | 2008 | 459 | 0.060 |
Why?
|
Child, Preschool | 3 | 2020 | 42577 | 0.060 |
Why?
|
Diet | 2 | 2021 | 8088 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3235 | 0.060 |
Why?
|
International Classification of Diseases | 1 | 2011 | 935 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2014 | 6214 | 0.060 |
Why?
|
Geography | 1 | 2007 | 651 | 0.060 |
Why?
|
Foreign Bodies | 1 | 2009 | 403 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9613 | 0.060 |
Why?
|
Body Mass Index | 2 | 2014 | 13050 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1182 | 0.060 |
Why?
|
Jejunoileal Bypass | 1 | 2023 | 13 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2008 | 7841 | 0.060 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 677 | 0.060 |
Why?
|
Manometry | 1 | 2006 | 458 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1265 | 0.050 |
Why?
|
Radiation Oncology | 1 | 2009 | 572 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7430 | 0.050 |
Why?
|
Pneumonia | 1 | 2015 | 2161 | 0.050 |
Why?
|
Heart Arrest | 1 | 2013 | 1516 | 0.050 |
Why?
|
Benzophenanthridines | 1 | 2002 | 27 | 0.050 |
Why?
|
Phenanthridines | 1 | 2002 | 50 | 0.050 |
Why?
|
Pressure | 1 | 2006 | 1172 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2009 | 1308 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 285 | 0.050 |
Why?
|
L-Iditol 2-Dehydrogenase | 1 | 2002 | 3 | 0.050 |
Why?
|
Genistein | 1 | 2002 | 87 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36570 | 0.050 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2002 | 33 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2007 | 1365 | 0.050 |
Why?
|
Lysophosphatidylcholines | 1 | 2002 | 77 | 0.050 |
Why?
|
Hepatic Artery | 1 | 2003 | 233 | 0.050 |
Why?
|
Extracorporeal Circulation | 1 | 2002 | 182 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20710 | 0.050 |
Why?
|
Alkaloids | 1 | 2002 | 192 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2010 | 1680 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16722 | 0.040 |
Why?
|
Research | 1 | 2009 | 1977 | 0.040 |
Why?
|
Diarrhea | 1 | 2007 | 1317 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2002 | 527 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2015 | 4306 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1418 | 0.040 |
Why?
|
Intestinal Diseases | 1 | 2024 | 506 | 0.040 |
Why?
|
Brazil | 1 | 2023 | 1250 | 0.040 |
Why?
|
Urban Population | 1 | 2007 | 2040 | 0.040 |
Why?
|
Signal Transduction | 1 | 2002 | 23618 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2011 | 1639 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9661 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 22248 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 693 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8728 | 0.040 |
Why?
|
Medical Oncology | 1 | 2009 | 2340 | 0.040 |
Why?
|
Flatulence | 1 | 2017 | 19 | 0.040 |
Why?
|
Digestion | 1 | 2017 | 53 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1252 | 0.040 |
Why?
|
Perfusion | 1 | 2002 | 1409 | 0.030 |
Why?
|
Smoking | 1 | 2014 | 9077 | 0.030 |
Why?
|
Population Surveillance | 1 | 2007 | 2594 | 0.030 |
Why?
|
Organ Preservation | 1 | 2020 | 400 | 0.030 |
Why?
|
Probability | 1 | 2002 | 2476 | 0.030 |
Why?
|
Cholesterol | 2 | 2003 | 2904 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2005 | 1310 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2121 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2007 | 1945 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2018 | 379 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3271 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2002 | 1874 | 0.030 |
Why?
|
Travel | 1 | 2021 | 806 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30214 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1627 | 0.030 |
Why?
|
Insurance, Health | 1 | 2007 | 2520 | 0.030 |
Why?
|
Fruit | 1 | 2020 | 1166 | 0.030 |
Why?
|
Ischemia | 1 | 2003 | 1905 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2019 | 968 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1587 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2002 | 4860 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2721 | 0.030 |
Why?
|
Infant | 1 | 2014 | 36459 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11514 | 0.020 |
Why?
|
Tissue Donors | 1 | 2002 | 2392 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2712 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3723 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2005 | 3306 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4188 | 0.020 |
Why?
|
Graft Survival | 1 | 2002 | 3904 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9744 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14653 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14073 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2028 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26309 | 0.020 |
Why?
|
Operating Rooms | 1 | 2015 | 790 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2012 | 592 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3942 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11062 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5873 | 0.020 |
Why?
|
Graft Rejection | 1 | 2002 | 4504 | 0.020 |
Why?
|
Bile Duct Diseases | 1 | 2008 | 98 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4252 | 0.020 |
Why?
|
Bacteria | 1 | 2018 | 2212 | 0.020 |
Why?
|
Bile Ducts | 1 | 2008 | 288 | 0.020 |
Why?
|
Animals | 4 | 2003 | 168939 | 0.020 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2008 | 236 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14762 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5513 | 0.010 |
Why?
|
Taurocholic Acid | 1 | 2003 | 43 | 0.010 |
Why?
|
Tissue Survival | 1 | 2003 | 120 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2002 | 18329 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 3208 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4880 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1788 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2008 | 2425 | 0.010 |
Why?
|
Bilirubin | 1 | 2003 | 440 | 0.010 |
Why?
|
Intestine, Small | 1 | 2007 | 1217 | 0.010 |
Why?
|
Plant Viruses | 1 | 1978 | 43 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3957 | 0.010 |
Why?
|
RNA, Viral | 1 | 1978 | 2867 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1978 | 12795 | 0.000 |
Why?
|
Oligoribonucleotides | 1 | 1978 | 46 | 0.000 |
Why?
|
Poly A | 1 | 1978 | 180 | 0.000 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1978 | 100 | 0.000 |
Why?
|
Guanosine Triphosphate | 1 | 1978 | 315 | 0.000 |
Why?
|
Methylation | 1 | 1978 | 1076 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1978 | 2093 | 0.000 |
Why?
|
Base Sequence | 1 | 1978 | 12415 | 0.000 |
Why?
|